ES2064071T3 - Antigeno viral de hepatitis delta, procedimiento para su purificacion y su utilizacion. - Google Patents

Antigeno viral de hepatitis delta, procedimiento para su purificacion y su utilizacion.

Info

Publication number
ES2064071T3
ES2064071T3 ES91830479T ES91830479T ES2064071T3 ES 2064071 T3 ES2064071 T3 ES 2064071T3 ES 91830479 T ES91830479 T ES 91830479T ES 91830479 T ES91830479 T ES 91830479T ES 2064071 T3 ES2064071 T3 ES 2064071T3
Authority
ES
Spain
Prior art keywords
purification
procedure
viral antigen
hepatitis delta
hdag
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91830479T
Other languages
English (en)
Inventor
Fabrizio Bonelli
Raffaele Calogero
Antonio Boniolo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sorin Biomedica SpA
Original Assignee
Sorin Biomedica SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11305904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2064071(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sorin Biomedica SpA filed Critical Sorin Biomedica SpA
Application granted granted Critical
Publication of ES2064071T3 publication Critical patent/ES2064071T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/40Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/70Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/735Fusion polypeptide containing domain for protein-protein interaction containing a domain for self-assembly, e.g. a viral coat protein (includes phage display)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/28011Hepeviridae
    • C12N2770/28111Hepevirus, e.g. hepatitis E virus
    • C12N2770/28122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

SE DESCRIBE UN COMPUESTO QUE COMPRENDE POLIPEPTIDOS RECOMBINADOS DE TIPO HDAG Y PARECIDOS AL HDAG, CON UNA ANTIGENICIDAD COMPARABLE CON LA MOLECULA NATURAL EXPRESADA EN LAS CELULAS INFECTADAS DE HDV DEL HIGADO HUMANO. SE DESCRIBE TAMBIEN EL PROCESO PARA LA PURIFICACION DE DICHAS MOLECULAS Y LAS PRUEBAS DE INMUNIDAD PARA EL USO DE LAS MISMAS.
ES91830479T 1990-11-05 1991-11-04 Antigeno viral de hepatitis delta, procedimiento para su purificacion y su utilizacion. Expired - Lifetime ES2064071T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT67865A IT1241003B (it) 1990-11-05 1990-11-05 Procedimento per la purificazione di un polipeptide ricombinante hdag equivalente, polipeptide hdag equivalente e saggi immunologici che lo utilizzano

Publications (1)

Publication Number Publication Date
ES2064071T3 true ES2064071T3 (es) 1995-01-16

Family

ID=11305904

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91830479T Expired - Lifetime ES2064071T3 (es) 1990-11-05 1991-11-04 Antigeno viral de hepatitis delta, procedimiento para su purificacion y su utilizacion.

Country Status (6)

Country Link
EP (1) EP0485347B1 (es)
AT (1) ATE111488T1 (es)
DE (1) DE69104012T2 (es)
ES (1) ES2064071T3 (es)
HK (1) HK1004267A1 (es)
IT (1) IT1241003B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1255660B (it) * 1992-06-08 1995-11-09 Sorin Biomedica Spa Composizioni stabilizzate di hdag.
US5445932A (en) * 1992-11-17 1995-08-29 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of a new marker associated with hepatitis delta virus infection
US6844171B1 (en) * 1998-07-02 2005-01-18 President And Fellows Of Harvard College Oligomerization of hepatitis delta antigen
CA2686427C (en) * 2007-05-08 2013-07-16 F. Hoffmann-La Roche Ag Method for the detection of specific immunoglobulin class g antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0175261B1 (en) * 1984-09-12 1991-12-11 Chiron Corporation Hybrid particle immunogens
DE3788902T3 (de) * 1986-06-17 2004-11-25 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Hepatitis-Delta-Diagnostika und Impfstoffe, ihre Herstellung und Verwendung.

Also Published As

Publication number Publication date
EP0485347A2 (en) 1992-05-13
IT9067865A1 (it) 1992-05-05
DE69104012T2 (de) 1995-05-11
IT1241003B (it) 1993-12-27
IT9067865A0 (it) 1990-11-05
EP0485347A3 (en) 1992-07-29
EP0485347B1 (en) 1994-09-14
DE69104012D1 (de) 1994-10-20
ATE111488T1 (de) 1994-09-15
HK1004267A1 (en) 1998-11-20

Similar Documents

Publication Publication Date Title
ES2188583T3 (es) Polipeptidos para el virus de la hepatitis c (hcv).
FI941199A0 (fi) Immunoreaktiiviset hepatiitti-C-viruksen polypeptidikoostumukset
CO5700784A2 (es) Polipeptidos de virus de papiloma humano y composiciones in- munogenas
ES2110411T3 (es) Metodos para cultivar el virus de la hepatitis c (hcv) en lineas celulares de linfocitos b o t.
DK149896C (da) Analogifremgangsmaade til fremstilling af lrf-analoge nona- eller decapeptidamider eller ikke-toksiske salte deraf
DK614987D0 (da) Syntetiske htlv-iii peptider, praeparater og anvendelser deraf
AR026059A1 (es) Virus de plantas modificadas y metodos para su uso
DK0491764T3 (da) Benzophenonether-estere, fremgangsmåde til deres fremstilling og deres anvendelse til forbedring af polyesterfarvningers lysstabilitet
DK0541692T3 (da) Herpes simplex virus VP-16-vacciner
DK354987D0 (da) Fremgangsmaade til fremstilling af floursulfonamider
DK267979A (da) Fremgangsmaade til fremstilling af aryloxypropanolaminer
ES2064071T3 (es) Antigeno viral de hepatitis delta, procedimiento para su purificacion y su utilizacion.
ES2105605T3 (es) Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas.
DE69737691D1 (de) Impfstoff, der peroxiredoxin enthält
DE3751834T2 (de) Selbstantigen der primären lebercirrhose
ES2179854T3 (es) Materiales aislados de felv prototipos para uso en modelos de enfermedades y vacunas.
ES2099287T3 (es) Procedimiento de separacion de un peptido de una resina.
ES2103104T3 (es) Nuevos compuestos di- y poliaminicos utiles en la preparacion de poliuretanos.
NO885231L (no) Peptidstrukturer, immunogener og anvendelse for fertilitetskontroll.
FI923020A (fi) Inte a inte b-sekvenser.
ES2039251T3 (es) Tratamiento del cabello.
ATE228568T1 (de) Herpesvirus-partikel zubereitung und vakzine
AR248047A1 (es) Procedimiento para la preparacion de una vacuna a base de virus del herpes bovina modificado tipo 1.
DK0555333T3 (da) Kunstige virushylstre
ES2155436T3 (es) Proteinas recombinantes con la reactividad inmunologica del antigeno e del virus de la hepatitis b (hbeag), procedimiento para su preparacion y su utilizacion en analisis inmunologicos y en vacunas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 485347

Country of ref document: ES